-transparent.png){kind=logo}
A specific thromboxane synthetase inhibitor, 3-methyl-2 (3-pyridyl)-1-indoleoctanoic acid (CGS 12970) was administered orally to 6 healthy adult Beagles at a dosage of 30 mg/kg of body weight. Blood generation of thromboxane B2 and urinary excretion of thromboxane B2 were measured before and after administration of CGS 12970. Although 97 +/- 0.4% inhibition of thromboxane B2 generation was observed within 2 hours after a single dose of CGS 12970 was administered orally, an effect on urinary excretion of thromboxane B2 was not observed. Additionally, oral administration of 30 mg/kg every 12 hours resulted in 80 +/- 14% inhibition of thromboxane B2 generation but had no effect on urinary thromboxane B2 excretion.
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
May 1992,
American journal of veterinary research,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
September 1987,
Research in veterinary science,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
January 1992,
Anesthesia and analgesia,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
March 1986,
Research in veterinary science,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
January 1987,
Nephron,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
March 1992,
European journal of pharmacology,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
May 1992,
Arerugi = [Allergy],
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
September 1992,
American journal of veterinary research,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
June 1997,
Basic research in cardiology,
S L Longhofer, and
H C Johnson, and
C A Culham, and
K T Schultz, and
G F Grauer
May 1985,
Prostaglandins,
